Patent
Methods and compositions for selecting siRNA of improved functionality
Anastasia Khvorova,Angela Reynolds,Devin Leake,William Marshall,Steven Read,Stephen Scaringe +5 more
- 12 May 2004
335
TL;DR: In this paper, a rational design of siRNAs for gene silencing is described, including those directed to the nucleotide sequences for HAO1, and methods for silencing genes.
read more
Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. Be selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods compositions, and kits generated through rational design of siRNAs are disclosed, including those directed to the nucleotide sequences for HAO1.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Processes for generating til products enriched for tumor antigen-specific t-cells
Cecile Chartier-Courtaud,Krit Ritthipichai +1 more
- 08 Jan 2019
TL;DR: In this article, the authors provide improved and/or shortened processes and methods for reprogramming TILs in order to prepare therapeutic populations of TIL with increased therapeutic efficacy.
1
Patent
Use of Substances for Sensitization of Tumor Cells to Radiation and/or Chemotherapy
Nils Cordes,Michael Baumann,Iris Eke,Ulrike Koch,Veit Sandfort +4 more
- 20 Feb 2009
TL;DR: In this article, the PINCH-1 protein was used to increase the sensitivity of tumor cells to treatment with radiation and/or chemotherapy, which was accomplished through the use of substances which block or limit the function of PINCH.
1
Patent
TREATMENT OF HEART DISEASE BY INHIBTION OF THE ACTION OF MUSCLE A-KINASE ANCHORING PROTEIN (mAKAP)
Kapiloff Michael S
- 10 Jan 2019
TL;DR: In this article, a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAPβ, or the expression or activity of one or both of those molecules.
1
Patent
Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
Wever Olivier De,An Hendrix,Wendy Westbroek +2 more
- 12 May 2010
TL;DR: In this paper, the prognosis of patients with estrogen receptor-positive breast cancer on the basis of Rab27B expression was evaluated and compounds which can be used to treat estrogen receptor positive breast cancer were disclosed.
1
Patent
Composition for reducing cellular senescence level including activity inhibitor inhibiting dcun1d3 activity or expression inhibitor inhibiting expression of dcun1d3-encoding gene and use thereof
Kim Myoungsoon,Yong-sub Kim,Young-Sam Lee +2 more
- 30 Jun 2016
TL;DR: In this paper, a composition and method for reducing a cellular senescence level by inhibiting the activity or expression of one or more of DCUN1D3 protein or gene encoding same and a polynucleotide having a nucleotide sequence of SEQ ID NO: 5 was presented.
1
References
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Andrew Fire,SiQun Xu,Mary K. Montgomery,Steven A. Kostas,Steven A. Kostas,Samuel E. Driver,Craig C. Mello +6 more
TL;DR: To their surprise, it was found that double-stranded RNA was substantially more effective at producing interference than was either strand individually, arguing against stochiometric interference with endogenous mRNA and suggesting that there could be a catalytic or amplification component in the interference process.
16.7K
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
TL;DR: 21-nucleotide siRNA duplexes provide a new tool for studying gene function in mammalian cells and may eventually be used as gene-specific therapeutics.
11.1K
RNA interference is mediated by 21- and 22-nucleotide RNAs
TL;DR: In this article, the authors demonstrate that 21 and 22-nt RNA fragments are the sequence-specific mediators of RNA interference in a Drosophila in vitro system, and provide evidence that the direction of dsRNA processing determines whether sense or antisense target RNA can be cleaved by the siRNA-protein complex.
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
Marianne Abifadel,Mathilde Varret,Jean-Pierre Rabès,Delphine Allard,Khadija Ouguerram,Martine Devillers,Corinne Cruaud,Suzanne Benjannet,Louise Wickham,D. Erlich,Aurélie Derré,Ludovic Villéger,Michel Farnier,Isabel Beucler,Eric Bruckert,Jean Chambaz,Bernard Chanu,Jean-Michel Lecerf,Gérald Luc,Philippe Moulin,Jean Weissenbach,Annick Prat,Michel Krempf,Claudine Junien,Nabil G. Seidah,Catherine Boileau +25 more
TL;DR: Two mutations in the gene PCSK9 (encoding proprotein convertase subtilisin/kexin type 9) that cause ADH are reported, a newly identified human subtilase that is highly expressed in the liver and contributes to cholesterol homeostasis.
3.1K
Functional siRNAs and miRNAs Exhibit Strand Bias
TL;DR: The results suggest that the thermodynamic properties of siRNA play a critical role in determining the molecule's function and longevity, possibly biasing the steps involved in duplex unwinding and strand retention by RISC.
2.8K